NASDAQ : ANAB
AnaptysBio, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 48.28 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.44B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
AnaptysBio, Inc. (ANAB) reported revenue of 106.09M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Revenue | 106.09M | 106.09M | 234.60M | 91.28M | 17.16M | 10.29M |
| Cost of Revenue | -5.34M | -5.34M | -3.64M | 11.49M | 132.28M | 88.80M |
| Gross Profit | 111.42M | 111.42M | 238.25M | 79.78M | -115.13M | -78.51M |
| Selling, General & Admin | 45.73M | 45.73M | 11.35M | 13.63M | 41.95M | 36.64M |
| Operating Expenses | 45.73M | 45.73M | 11.35M | 13.63M | 41.95M | 36.64M |
| Operating Income | 65.70M | 65.70M | 226.90M | 66.15M | -157.07M | -115.15M |
| Interest Expense | -82.38M | -82.38M | -79.89M | -50.09M | -18.08M | -21.11M |
| Interest & Investment Income | 6.50M | 6.50M | 9.81M | 15.07M | 18.87M | 7.55M |
| Currency Exchange Gain (Loss) | 12.00K | |||||
| Other Non Operating Income (Expenses) | -2.00K | -2.00K | 5.45M | -2.00K | ||
| EBT Excluding Unusual Items | -10.19M | -10.19M | 162.28M | 31.14M | -156.28M | -128.70M |
| Pretax Income | -10.19M | -10.19M | 162.28M | 31.14M | -163.62M | -128.70M |
| Income Tax Expense | -362.90M | -362.90M | 772.00K | 158.00K | -4.00K | 24.00K |
| Earnings From Continuing Operations | 352.72M | 352.72M | 161.50M | 30.98M | -163.62M | -128.72M |
| Earnings From Discontinued Operations | -90.72M | -90.72M | -174.74M | -176.21M | ||
| Net Income | 261.99M | 261.99M | -13.23M | -145.23M | -163.62M | -128.72M |
| Net Income to Common | 261.99M | 261.99M | -13.23M | -145.23M | -163.62M | -128.72M |
| Shares Outstanding (Basic) | 28.98M | 28.98M | 28.76M | 28.38M | 26.92M | 28.16M |
| Shares Outstanding (Diluted) | 37.48M | 37.48M | 30.23M | 29.54M | 26.92M | 28.16M |
| EPS (Basic) | 9.04 | 9.04 | -0.46 | -5.12 | -6.08 | -4.57 |
| EPS (Diluted) | 7.00 | 7.00 | -0.44 | -4.91 | -6.08 | -4.57 |
| Free Cash Flow | -105.12M | -105.12M | 19.70M | -135.34M | -121.61M | -73.95M |
| Free Cash Flow Per Share | -2.81 | -2.81 | 0.65 | -4.58 | -4.52 | -2.63 |
| Gross Margin | 105.03% | 105.03% | 101.55% | 87.41% | ||
| Operating Margin | 61.93% | 61.93% | 96.72% | 72.47% | -915.50% | -1,119.41% |
| Profit Margin | 246.96% | 246.96% | -5.64% | -159.11% | -953.66% | -1,251.33% |
| Free Cash Flow Margin | -99.09% | -99.09% | 8.40% | -148.27% | -708.79% | -718.88% |
| EBITDA | 65.71M | 65.71M | 226.92M | 66.17M | -156.42M | -114.48M |
| EBITDA Margin | 61.94% | 61.94% | 96.73% | 72.49% | ||
| D&A For EBITDA | 18.00K | 18.00K | 20.00K | 20.00K | 652.00K | 675.00K |
| EBIT | 65.70M | 65.70M | 226.90M | 66.15M | -157.07M | -115.15M |
| EBIT Margin | 61.93% | 61.93% | 96.72% | 72.47% | ||
| Effective Tax Rate | 0.48% | 0.51% |
Balance sheet
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 133.83M | 133.83M | 138.20M | 23.08M | 35.97M | 71.31M |
| Short-Term Investments | 30.32M | 30.32M | 73.44M | 262.29M | 354.94M | 369.93M |
| Cash & Short-Term Investments | 164.14M | 164.14M | 211.64M | 285.37M | 390.90M | 441.24M |
| Accounts Receivable | 25.63M | 25.63M | 33.85M | 40.77M | 6.85M | 1.42M |
| Other Receivables | 6.00M | 6.00M | ||||
| Receivables | 31.63M | 31.63M | 33.85M | 40.77M | 6.85M | 1.42M |
| Prepaid Expenses | 2.65M | 2.65M | 1.18M | 9.08M | 4.54M | |
| Other Current Assets | 104.76M | 104.56M | ||||
| Total Current Assets | 198.43M | 198.43M | 350.25M | 431.88M | 406.83M | 447.20M |
| Property, Plant & Equipment | 11.66M | 11.66M | 12.63M | 14.51M | 18.27M | 19.99M |
| Long-Term Investments | 35.47M | 27.03M | 142.94M | |||
| Long-Term Deferred Tax Assets | 106.64M | 106.64M | ||||
| Other Long-Term Assets | 256.00K | 256.00K | 1.51M | 1.97M | 256.00K | 256.00K |
| Total Assets | 316.98M | 316.98M | 364.39M | 483.83M | 452.39M | 610.38M |
| Accounts Payable | 4.39M | 4.39M | 3.87M | 4.00M | 4.70M | 2.78M |
| Accrued Expenses | 28.80M | 28.80M | 32.29M | 39.50M | 30.51M | 21.63M |
| Current Portion of Leases | 2.16M | 2.16M | 2.08M | 1.93M | 1.78M | 1.64M |
| Other Current Liabilities | 382.00K | 456.00K | ||||
| Total Current Liabilities | 35.35M | 35.35M | 38.62M | 45.43M | 37.44M | 26.05M |
| Long-Term Debt | 256.49M | 256.49M | 276.53M | 353.43M | 310.81M | 304.41M |
| Long-Term Leases | 10.93M | 10.93M | 12.03M | 14.11M | 16.04M | 17.81M |
| Other Long-Term Liabilities | 3.62M | 3.62M | ||||
| Total Liabilities | 306.40M | 306.40M | 327.19M | 412.97M | 364.29M | 348.28M |
| Common Stock | 30.00K | 30.00K | 28.00K | 30.00K | 27.00K | 29.00K |
| Additional Paid-In Capital | 652.27M | 652.27M | 809.76M | 829.86M | 702.97M | 717.80M |
| Retained Earnings | -641.56M | -641.56M | -772.56M | -759.33M | -614.10M | -450.48M |
| Comprehensive Income & Other | -151.00K | -151.00K | -24.00K | 305.00K | -797.00K | -5.25M |
| Total Common Equity | 10.59M | 10.59M | 37.21M | 70.87M | 88.10M | 262.10M |
| Shareholders' Equity | 10.59M | 10.59M | 37.21M | 70.87M | 88.10M | 262.10M |
| Total Liabilities & Equity | 316.98M | 316.98M | 364.39M | 483.83M | 452.39M | 610.38M |
| Total Debt | 269.59M | 269.59M | 290.64M | 369.46M | 328.62M | 323.86M |
| Net Cash (Debt) | -105.44M | -105.44M | -79.00M | -84.09M | 62.28M | 117.38M |
| Net Cash Per Share | -2.81 | -2.81 | -2.61 | -2.85 | 2.31 | 4.17 |
| Filing Date Shares Outstanding | 29.90M | 29.90M | 28.75M | 30.67M | 26.76M | 27.93M |
| Total Common Shares Outstanding | 29.73M | 29.73M | 28.02M | 30.47M | 26.60M | 28.51M |
| Working Capital | 163.07M | 163.07M | 311.62M | 386.45M | 369.39M | 421.15M |
| Book Value Per Share | 0.36 | 0.36 | 1.33 | 2.33 | 3.31 | 9.19 |
| Tangible Book Value | 10.59M | 10.59M | 37.21M | 70.87M | 88.10M | 262.10M |
| Tangible Book Value Per Share | 0.36 | 0.36 | 1.33 | 2.33 | 3.31 | 9.19 |
| Machinery | 8.11M | 7.46M | ||||
| Leasehold Improvements | 203.00K | 203.00K | 203.00K | 203.00K | 203.00K | 203.00K |
Cash flow statement
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | 261.99M | 261.99M | -13.23M | -145.23M | -163.62M | -128.72M |
| Depreciation & Amortization | 1.94M | 1.94M | 1.88M | 1.81M | 2.38M | 2.33M |
| Loss (Gain) From Sale of Investments | 60.00K | 60.00K | -4.73M | -10.31M | -10.52M | -2.51M |
| Stock-Based Compensation | 16.64M | 16.64M | 3.77M | 7.22M | 33.20M | 27.36M |
| Other Operating Activities | -285.01M | -285.01M | 79.89M | 50.09M | 18.08M | 21.11M |
| Change in Accounts Receivable | 16.43M | 16.43M | 6.92M | -33.91M | -5.43M | -543.00K |
| Change in Accounts Payable | -89.71M | -89.71M | -87.33M | -33.84M | 10.94M | 9.70M |
| Change in Income Taxes | -6.49M | -6.49M | ||||
| Change in Other Net Operating Assets | -9.38M | -9.38M | -111.00K | -1.67M | -5.83M | -2.32M |
| Operating Cash Flow | -105.12M | -105.12M | 19.70M | -135.34M | -120.80M | -73.59M |
| Capital Expenditures | -807.00K | -358.00K | ||||
| Investment in Securities | 85.09M | 85.09M | 228.12M | 31.72M | 145.56M | -394.49M |
| Other Investing Activities | -87.00K | -358.00K | ||||
| Investing Cash Flow | 85.09M | 85.09M | 228.03M | 31.36M | 144.75M | -394.85M |
| Issuance of Common Stock | 50.74M | 50.74M | 14.26M | 100.84M | 2.47M | 11.83M |
| Repurchase of Common Stock | -68.63M | -456.00K | -50.00M | |||
| Other Financing Activities | -239.45M | -239.45M | -78.25M | 26.67M | -11.77M | 32.19M |
| Financing Cash Flow | -188.71M | -188.71M | -132.61M | 127.05M | -59.30M | 44.02M |
| Net Cash Flow | -208.74M | -208.74M | 115.12M | 23.08M | -35.34M | -424.42M |
| Free Cash Flow | -105.12M | -105.12M | 19.70M | -135.34M | -121.61M | -73.95M |
| Free Cash Flow Margin | -99.09% | -99.09% | 8.40% | -148.27% | -708.79% | -718.88% |
| Free Cash Flow Per Share | -2.81 | -2.81 | 0.65 | -4.58 | -4.52 | -2.63 |
| Levered Free Cash Flow | 98.47M | -103.66M | -73.42M | -46.19M | ||
| Unlevered Free Cash Flow | 148.40M | -72.36M | -62.12M | -33.00M | ||
| Cash Interest Paid | 83.00M | 83.00M | 79.99M | 42.13M | ||
| Cash Income Tax Paid | 11.16M | 11.16M | 78.00K | |||
| Change in Working Capital | -89.14M | -89.14M | -80.53M | -69.42M | -324.00K | 6.84M |
Ratios
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.44B | 2.00B | 1.34B | 402.88M | 569.24M | 881.10M |
| Enterprise Value | 1.55B | 1.99B | 1.44B | 339.82M | 485.70M | 759.56M |
| Last Close Price | 48.28 | 67.50 | 32.32 | 8.83 | 14.28 | 20.66 |
| PE Ratio | 6.90 | 7.63 | ||||
| Forward PE | 17.19 | 37.90 | 14.68 | 14.68 | 14.68 | 14.68 |
| PS Ratio | 13.61 | 18.84 | 5.72 | 4.41 | 33.18 | 85.65 |
| PB Ratio | 135.59 | 188.81 | 36.08 | 5.68 | 6.46 | 3.36 |
| P/TBV Ratio | 136.36 | 188.81 | 36.08 | 5.68 | 6.46 | 3.36 |
| P/FCF Ratio | 68.15 | |||||
| P/OCF Ratio | 68.15 | |||||
| EV/Sales Ratio | 14.60 | 18.75 | 6.14 | 3.72 | 28.31 | 73.84 |
| EV/EBITDA Ratio | 23.57 | 30.27 | 6.34 | 5.13 | ||
| EV/EBIT Ratio | 23.58 | 30.28 | 6.35 | 5.14 | ||
| EV/FCF Ratio | 73.10 | |||||
| Debt / Equity Ratio | 25.47 | 25.47 | 7.81 | 5.21 | 3.73 | 1.24 |
| Debt / EBITDA Ratio | 4.10 | 4.10 | 1.27 | 5.38 | ||
| Debt / FCF Ratio | 14.76 | |||||
| Net Debt / Equity Ratio | 9.96 | 9.96 | 2.12 | 1.19 | -0.71 | -0.45 |
| Net Debt / EBITDA Ratio | 1.60 | 1.60 | 0.35 | 1.27 | 0.40 | 1.02 |
| Net Debt / FCF Ratio | -1.00 | -1.00 | 4.01 | -0.62 | 0.51 | 1.59 |
| Asset Turnover | 0.55 | 0.20 | 0.03 | 0.02 | ||
| Quick Ratio | 5.54 | 5.54 | 6.36 | 7.18 | 10.62 | 16.99 |
| Current Ratio | 5.61 | 5.61 | 9.07 | 9.51 | 10.87 | 17.16 |
| Return on Equity (ROE) | 298.86% | 38.98% | -93.44% | -41.62% | ||
| Return on Assets (ROA) | 33.44% | 8.83% | -18.47% | -11.48% | ||
| Return on Invested Capital (ROIC) | 56.62% | 56.57% | 166.55% | 72.81% | -184.20% | -102.31% |
| Return on Capital Employed (ROCE) | 23.30% | 23.30% | 69.70% | 15.10% | -37.90% | -19.70% |
| Earnings Yield | 14.50% | 13.11% | -0.99% | -36.05% | -28.74% | -14.61% |
| FCF Yield | -7.28% | -5.26% | 1.47% | -33.59% | -21.36% | -8.39% |
| Buyback Yield / Dilution | -26.17% | -23.96% | -2.33% | -9.73% | 4.41% | -2.68% |